课题基金 / 基金详情

HIVIG PREVENTION OF MATERNAL/FETAL HIV TRANSMISION IN PREGNANT WOMEN

HIVIG PREVENTION OF MATERNAL/FETAL HIV TRANSMISION IN PREGNANT WOMEN
HIVIG 预防孕妇母体/胎儿 HIV 传播
批准号:
6116753
负责人:
William Thomas Shearer
金额:
$3.6万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1998
资助国家:
美国
项目状态:
已结题
起止时间:
1998-12-01 至 1999-11-30

项目摘要

项目成果

William Thomas Shearer的其他基金

相似基金

相关文献

中文摘要
翻译
本研究假设高免抗HIV静脉注射免疫球蛋白(HIVIG)对HIV感染孕妇及其新生儿应用ZDV预防HIV垂直传播是有效、安全和可耐受的。这项研究被数据、安全和监测委员会停止,因为使用目前预计的患者数量缺乏有效性,而且由于进展缓慢。一个重要的发现是,治疗和对照患者的艾滋病毒垂直传播率都不到5%,比之前的研究数据有所改善。
英文摘要
This study hypothesizes that hyperimmune anti-HIV intravenous immunoglobulin (HIVIG) will be efficacious, safe, and tolerable when administered with ZDV to HIV-infected pregnant women and their newborn infants for prevention of vertical transmission of HIV. This study was stopped by the Data, Safety, and Monitoring Board because of lack of efficacy using the currently projected number of patients and because of slow accrual. One important finding was that both treatment and control patients had a vertical HIV transmission rate of less than 5%, an improvement over previous research data.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
PACTG P1026S (VERSION 20), PHARMACOKINETIC PROPERTIES OF ANTIRETROVIRAL DRUG
  • 批准号:
    8356662
  • 项目类别:
  • 资助金额:
    $4.13万
  • 财政年份:
    2010
  • 负责人:
    William Thomas Shearer
  • 依托单位:
A5240 (VERSION 10) A PHASE II STUDY TO EVALUATE THE IMMUNOGENICITY AND SAFETY
  • 批准号:
    8356728
  • 项目类别:
  • 资助金额:
    $2.64万
  • 财政年份:
    2010
  • 负责人:
    William Thomas Shearer
  • 依托单位:
IMPAACT 1077HS (VS 10) HAART STANDARD VERSION OF THE PROMISE STUDY
  • 批准号:
    8356740
  • 项目类别:
  • 资助金额:
    $0.79万
  • 财政年份:
    2010
  • 负责人:
    William Thomas Shearer
  • 依托单位:
Baylor College of Medicine Clinical Trial Unit
  • 批准号:
    8138733
  • 项目类别:
  • 资助金额:
    $15.35万
  • 财政年份:
    2010
  • 负责人:
    William Thomas Shearer
  • 依托单位:
海外基金